Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-24-050723

President & COO sold 354,604 shares at an average $11.68 ($4,141,662)

  • President & COO acquired 500,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Venker Eric President & COO 2024-12-27 Option exercise +250,000 $3.85 $962,500 845,580 D
Venker Eric President & COO 2024-12-27 Sale −176,900 $11.82 $2,090,958 668,680 D
Venker Eric President & COO 2024-12-30 Option exercise +250,000 $3.85 $962,500 918,680 D
Venker Eric President & COO 2024-12-30 Sale −177,704 $11.54 $2,050,704 740,976 D
Derivatives
Venker Eric President & COO 2024-12-27 Option exercise · Stock Option (Right to Buy) −250,000 11,976,234 D
Venker Eric President & COO 2024-12-30 Option exercise · Stock Option (Right to Buy) −250,000 11,726,234 D
Open-market sales · 354,604 sh · avg $11.68 · $4,141,662
Loading xslF345X05/form4.xml…